JPRN-UMIN000023248
Completed
未知
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIs - JP-CLEAR (Japanese Prospective evaluation of tumor-derived Circulating DNA Liquid biopsy in patients with EGFR-mutant NSCLC during and after Acquired Resistance to EGFR-TKI treatment)
PHRF0 sites122 target enrollmentJuly 20, 2016
Conditionson-small cell Lung Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell Lung Cancer
- Sponsor
- PHRF
- Enrollment
- 122
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Prior treatment with EGFR\-TKI 2\)HBsAg or HCV\-RNA positive Patients 3\)HIV positive Patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-511317-38-00Fundacion GECP33
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-002369-36-ESFundación GECP30
Recruiting
Not Applicable
Exploratory research of liquid biopsy for patients with cancercancerJPRN-UMIN000033269Cancer Precision Medicine Center Cancer Institute,800
Recruiting
Not Applicable
Validation process of liquid biopsy for solid tumorsHealth Condition 1: D499- Neoplasm of unspecified behavior of unspecified siteCTRI/2023/03/050258Cancer Research and Statistic Foundation CRSF
Not yet recruiting
Not Applicable
Exploratory analysis of liquid biopsy for the predictive factors associated with outcome of PD-1 Pathway Blockade in Multicenter Studynon-small cell lung cancerJPRN-jRCT1032220559Ohe Yuichiro100